QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.106.106757v1 318/3/1006    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hansen, H. H. Articles by Mikkelsen, J. D. Search for Related Content PubMed PubMed Citation Articles by Hansen, H. H. Articles by Mikkelsen, J. D.

NEUROPHARMACOLOGY

The KCNQ Channel Opener Retigabine Inhibits the Activity of Mesencephalic Dopaminergic Systems of the Rat

Departments of Functional Neuroanatomy and Biomarkers (H.H.H., C.E., J.D.M.), In Vivo Pharmacology (C.M.), Microdialysis (P.W.), and Neurodegeneration and Repair (L.C.R.), NeuroSearch A/S, Ballerup, Denmark; and Department of Pharmacology and Research Center for Cellular and Molecular Neurobiology, University of Liege, Liege, Belgium (O.W., J.S.-M., V.S.)

Homo- and heteromeric complexes of KCNQ channel subunits are the molecular correlate of the M-current, a neuron-specific voltage-dependent K⁺ current with a well established role in control of neural excitability. We investigated the effect of KCNQ channel modulators on the activity of dopaminergic neurons in vitro and in vivo in the rat ventral mesencephalon. The firing of dopaminergic neurons recorded in mesencephalic slices was robustly inhibited in a concentration-dependent manner by the KCNQ channel opener N-(2-amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester (retigabine). The effect of retigabine persisted in the presence of tetrodotoxin and simultaneous blockade of GABA_A receptors, small-conductance calcium-activated K⁺ (SK) channels, and hyperpolarization-activated (I_h) channels, and it was potently reversed by the KCNQ channel blocker 4-pyridinylmethyl-9(10H)-anthracenone (XE991), indicating a direct effect on KCNQ channels. Likewise, in vivo single unit recordings from dopaminergic neurons revealed a prominent reduction in spike activity after systemic administration of retigabine. Furthermore, retigabine inhibited dopamine synthesis and c-Fos expression in the striatum under basal conditions. Retigabine completely blocked the excitatory effect of dopamine D₂ autoreceptor antagonists. Again, the in vitro and in vivo effects of retigabine were completely reversed by preadministration of XE991. Dual immunocytochemistry revealed that KCNQ4 is the major KCNQ channel subunit expressed in all dopaminergic neurons in the mesolimbic and nigrostriatal pathways. Collectively, these observations indicate that retigabine negatively modulates dopaminergic neurotransmission, likely originating from stimulation of mesencephalic KCNQ4 channels.

Address correspondence to: Dr. Jens D. Mikkelsen, NeuroSearch A/S, Pederstrupvej 93, DK-2750 Ballerup, Denmark. E-mail: jdm{at}neurosearch.dk

This article has been cited by other articles:

				H. H. Hansen, O. Waroux, V. Seutin, T. J. Jentsch, S. Aznar, and J. D. Mikkelsen Kv7 channels: interaction with dopaminergic and serotonergic neurotransmission in the CNS J. Physiol., April 1, 2008; 586(7): 1823 - 1832. [Abstract] [Full Text] [PDF]

				H. S. Jensen, M. Grunnet, and S.-P. Olesen Inactivation as a New Regulatory Mechanism for Neuronal Kv7 Channels Biophys. J., April 15, 2007; 92(8): 2747 - 2756. [Abstract] [Full Text] [PDF]

				S. Koyama, M. S. Brodie, and S. B. Appel Ethanol Inhibition of M-Current and Ethanol-Induced Direct Excitation of Ventral Tegmental Area Dopamine Neurons J Neurophysiol, March 1, 2007; 97(3): 1977 - 1985. [Abstract] [Full Text] [PDF]